OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Endocrinology Diabetes and Obesity is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Maximizing diabetes education efforts in vulnerable populations – newer delivery concepts	34
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	33
Public health concerns and increased risk of severe COVID-19 disease through androgen use	31
Updates in thyroid healthcare delivery: advancing patient-centered care	30
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	30
Advances in assessment and treatment of bone, mineral and parathyroid disorders	25
The female athlete triad: review of current literature	25
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	24
Nutrition and thyroid disease	23
Advances in the care of lipodystrophies	22
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	21
Editorial introduction	21
Editorial introduction	21
Editorial introductions	20
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	20
Financial toxicity in thyroid cancer survivors	20
Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare	20
An update on bone in diabetes	19
Recent advances in anaplastic thyroid cancer management	19
Interactions between antidiabetes medications and heart–brain axis	19
Preventing type 1 diabetes development and preserving beta-cell function	18
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency	17
Update on fracture risk assessment in osteoporosis	16
The use of anabolic agents in the treatment of osteoporosis: a clinical update	16
Editorial introduction	15

Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	14
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	14
Epidemiologic changes in thyroid disease	14
Gastrointestinal hormones and regulation of gastric emptying	14
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	13
Lipidomics in diabetes	12
Fibrous dysplasia in children and its management	12
Long-acting amylin analogues for the management of obesity	12
Type 2 diabetes: a contemporary view from the Asian lens	11
Precision medicine in diabetes care	11
The uncommon forms of congenital adrenal hyperplasia	11
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	11
Growth and development in type 1 diabetes	10
Glucocorticoid withdrawal syndrome: what to expect and how to manage	10
Effects of marijuana on reproductive health: preconception and gestational effects	10
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	10
A short history of saturated fat: the making and unmaking of a scientific consensus	10
Assisted reproductive technology outcomes and management considerations for people with epilepsy	10
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	10
An update on investigation and management of renal bone disease	10
Adrenal insufficiency and pregnancy	9
Legislation, medicine, and politics: care for gender diverse youth	9
Time to cycle regularity and health risks	8
Novel techniques for assessment of bone tissue material properties	8
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation	8
Editorial introductions	8
Editorial introductions	8
Indications for testosterone therapy in men	8
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	8
Editorial introductions	8
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective	7
Multifactorial chylomicronemia syndrome	7
Early anthropometric indicators of type 2 diabetes mellitus	7
An Update on Vitamin D Deficiency in the twenty-first century: nature and nurture	7
The interaction between gut microbiome and bone health	7
Continuous glucose monitoring in primary care – are we there?	7
Androgen abuse among gay and bisexual men	7
Microplastics, cardiometabolic risk, genetics and Alzheimer's disease	6
The psychosocial impact of thyroid cancer	6
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome	6
Editorial introductions	6
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?	6
Advanced imaging and theranostics in thyroid cancer	6
Polygenic risk scores for the diagnosis and management of dyslipidemia	6
Current challenges in Cushing's syndrome testing: blood, saliva, urine, or hair?	6
Bridging the LatinX community care gap	6
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	6
Type 2 diabetes mellitus and cognitive function: understanding the connections	6
Predictors of cardiovascular risk in familial hypercholesterolemia	6
When history, law, and medicine intersect	6

Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases	6
Radiofrequency ablation (RFA) compared to observation for benign thyroid nodules: emerging considerations for judicious use	5
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials	5
Fracture prediction tools in diabetes	5
HDL functionality in type 1 and type 2 diabetes: new insights	5
Editorial: New horizons for thyroid diseases: transformative changes and tailored care	5
Gastrointestinal regulatory peptides	5
Recent advances in the role of miRNAs in bone disease	5
Skeletal health in diabetes	5
Aggression and criminality in androgen abusers	4
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony	4
Prediabetes and skeletal health	4
Mixed-methods research on androgen abuse – a review	4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes	4
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?	4
Potassium-competitive acid blockers and acid-related disorders	4
Utilizing point-of-care A1c to impact outcomes – can we make it happen in primary care?	4
Bone marrow adiposity in diabetes and clinical interventions	4
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?	4
Hypoparathyroidism update	3
Better care for women with polycystic ovary syndrome – a proposal for an international evidence based best practice framework to improve care	3
Cardiometabolic risk and therapeutic outcomes in mild autonomous cortisol secretion	3
The approaches and challenges in the management of differentiated thyroid carcinoma	3
An update: maternal iodine supplementation, thyroid function tests, and child neurodevelopmental outcomes	3
Cardiovascular disease in metabolic-associated fatty liver disease	3
Editorial introductions	3
Subclinical hyperthyroidism	3
Differences in the management of thyroid nodules in children and adolescents as compared to adults	3
Body composition in sexual precocity	3
Update on management of paediatric dyslipidaemia	3
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms	3
Editorial: Childhood endocrine and genetic disorders: improving adult outcomes	3
Growth and development in monogenic forms of neonatal diabetes	3
Emerging treatment for congenital adrenal hyperplasia	3
Use of calculated free testosterone in men: advantages and limitations	2
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia	2
Addressing genetic and environmental sources of cardiometabolic disease	2
Effects of diabetes on osteocytes	2
Editorial overview	2
Effect of incretins on skeletal health	2
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome	2
Glucagon-like peptide-1 receptor agonists and safety in the preconception period	2
Editorial introductions	2
An overview of persistent chylomicronemia: much more than meets the eye	2
Molecular testing for indeterminate thyroid nodules: past, present, and future	2
Benefits and risks of apps for patients	2
Molecular tools for diagnosing diseases of the adrenal cortex	2
Editorial introduction	2
Selective progesterone receptor modulators and reproductive health	2
Enteroendocrine cell differentiation and function in the intestine	2
Under and overtreatment with thyroid hormone replacement during pregnancy	2
Mouse models of type 1 diabetes and their use in skeletal research	2
Editorial introduction	2
Editorial introductions	2
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?	2
Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease	2
Current perspectives on biomarkers in metabolic bone disease	2
Health effects of androgen abuse: a review of the HAARLEM study	2